Seeing Is Believing
Healthcare - Sector
KYMR is currently covered by 22 analysts with an average price target of $129.44. This is a potential downside of $2.29 (-1.74%) from yesterday's end of day stock price of $131.73.
Kymera Therapeutics's activity chart (see below) currently has 214 price targets and 208 ratings on display. The stock rating distribution of KYMR is 94.23% BUY and 5.77% HOLD.
Analysts average stock forecasts to be materialized ratio is 90.49% with an average time for these price targets to be met of 292.94 days.
Highest price target for KYMR is $170, Lowest price target is $97, average price target is $129.44.
Most recent stock forecast was given by BRIAN ABRAHAMS from RBC on 02-Nov-2026. First documented stock forecast 15-Sep-2020.
Currently out of the existing stock ratings of KYMR, 49 are a BUY (94.23%), 3 are a HOLD (5.77%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 02-Nov-2026
$116
$-15.73 (-11.94%)
$112
6 days ago
(02-Nov-2026)
4/6 (66.67%)
$-10.63 (-8.39%)
100
Buy Since 30-Jun-2023
$150
$18.27 (13.87%)
$136
6 days ago
(02-Nov-2026)
14/15 (93.33%)
$23.37 (18.46%)
179
Buy Since 20-May-2021
$170
$38.27 (29.05%)
$139
6 days ago
(02-Nov-2026)
5/7 (71.43%)
$43.37 (34.25%)
549
Buy Since 27-Oct-2026
$146
$14.27 (10.83%)
$79
12 days ago
(27-Oct-2026)
2/3 (66.67%)
$31.16 (27.13%)
97
Buy Since 27-Jun-2025
$150
$18.27 (13.87%)
$120
1 months 3 days ago
(05-Oct-2026)
8/9 (88.89%)
$40.15 (36.55%)
116
What is KYMR (Kymera Therapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on KYMR (Kymera Therapeutics)?
Which analyst has the most public recommendations on KYMR (Kymera Therapeutics)?
Which analyst is the currently most bullish on KYMR (Kymera Therapeutics)?
Which analyst is the currently most reserved on KYMR (Kymera Therapeutics)?